1036991-24-8

Basic information

• Product Name: 6-Dimethylaminopyridine-3-boronic acid pinacol ester
• Synonyms: 6-Dimethylaminopyridine-3-boronic acid pinacol ester;2-(Dimethylamino)pyridine-5-boronic acid pinacol ester;N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine(SALTDATA: FREE);N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine;N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
• CAS NO: 1036991-24-8
• Molecular Formula: C₁₃H₂₁BN₂O₂
• Molecular Weight: 266.14432
• Mol File: 1036991-24-8.mol
• Article Data: 11

Chemical Properties

• Melting Point: 89-90 °C
• Boiling Point: 358.5±27.0 °C(Predicted)
• Appearance: /
• Density: 1.04±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 6.98±0.10(Predicted)
• CAS DataBase Reference: 6-Dimethylaminopyridine-3-boronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Dimethylaminopyridine-3-boronic acid pinacol ester(1036991-24-8)
• EPA Substance Registry System: 6-Dimethylaminopyridine-3-boronic acid pinacol ester(1036991-24-8)

Safety Data

• Hazard Codes: Xi
• Statements: 43
• Safety Statements: 36/37
• Hazardous Substances Data: 1036991-24-8(Hazardous Substances Data)

Usage

Uses

6-(Dimethylamino)pyridine-3-boronic acid pinacol ester

InChI:InChI=1S/C13H21BN2O2/c1-12(2)13(3,4)18-14(17-12)10-7-8-11(15-9-10)16(5)6/h7-9H,1-6H3

Upstream product

• 26163-07-5 5-bromo-2-dimethylaminopyridine 
• 73183-34-3 bis(pinacol)diborane 
• 5683-33-0 2-(Dimethylamino)pyridine 
• 766-11-0 5-bromo-2-fluoropyridine 

Downstream Products

• 1374328-49-0 N,N-dimethyl-5-phenylpyridin-2-amine 

Relevant articles and documents

Cobalt-catalyzed C-H borylation

A family of pincer-ligated cobalt complexes has been synthesized and are active for the catalytic C-H borylation of heterocycles and arenes. The cobalt catalysts operate with high activity and under mild conditions and do not require excess borane reagents. Up to 5000 turnovers for methyl furan-2-carboxylate have been observed at ambient temperature with 0.02 mol % catalyst loadings. A catalytic cycle that relies on a cobalt(I)-(III) redox couple is proposed.

DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY

Provided herein are compounds of the Formula (I), (II), and (III), as well as pharmaceutically acceptable salts thereof, wherein the substituents are those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of oncologic diseases.

SUBSTITUTED BENZAZINONES AS ANTIBACTERIAL COMPOUNDS

The present invention relates to LpxC antibacterial compounds of Formula (1A), corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions:, compound preparation, treatment methods and uses for bacterial infections, especially those caused by gram-negative bacteria.

PHOSPHOINOSITIDE 3-KINASE INHIBITORS WITH ZINC BINDING MOIETY

PROBLEM TO BE SOLVED: To provide phosphoinositide 3-kinase inhibitors with a zinc binding moiety. SOLUTION: There is provided a compound represented by formula (I) in the figure. (X is S, O or the like; Y is CH, N or the like; G1 is optionally substituted N or the like; R1 and R2 are each independently H or the like; C is a substituted heterocycle or the like; B is a linear alkyl or the like; Ra and Rb together with the nitrogen atom coupled to them are morpholino or the like; G2 is an indazole ring or the like; q, r and s are independently from 0 to 1, provided that at least one of them is 1; t is from 0 to 1; n is from 0 to 4; and p is from 0 to 2.) COPYRIGHT: (C)2016,JPOandINPIT